CLINICAL_TRIALS
trial_result
· 2015-12-08
Clinical Trial Update: Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia [Phase 1]
Summary
Phase 1 safety study of ON 013105 in lymphoma and acute lymphoblastic leukemia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Traws Pharma, Inc. | Conditions: Lymphoma, Acute Lymphocytic Leukemia | Phase 1 | Status: TERMINATED